DocDollars

La Jolla Pharmaceutical Company

MA · United States · Reporting entity ID 100000231830

Total reported 2019–2025
$5.96M
#651 of 2,960 reporting companies — 0% of all reported industry payments
$3.16M in general payments across 18,786 records, plus $2.80M in research funding across 309 records.

How it breaks down

General payments $3,160,408
Research funding $2,797,988

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

La Jolla Pharmaceutical Company reported $5.96M to US doctors and teaching hospitals from 2019 to 2025, ranking #651 of 2,960 reporting companies. 47% of that was research funding and 53% general payments such as consulting, speaking, food and travel. 18,786 general payment records and 309 research records were filed.

Common questions about La Jolla Pharmaceutical Company

How much has La Jolla Pharmaceutical Company paid US doctors?

La Jolla Pharmaceutical Company reported $5,958,395 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $3,160,408 in general payments, $2,797,988 in research funding.

How does La Jolla Pharmaceutical Company rank among drug and device companies?

It ranks #651 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from La Jolla Pharmaceutical Company mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.